IKT Inhibikase Therapeutics, Inc. Common Stock BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

Inhibikase Therapeutics (IKT) Stock: Buy, Sell, or Hold?

$1.52
-0.01 (-0.65%) â–ŧ
5d: +1.33% 30d: -16.94% 90d: -36.4%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
48/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.51 – $1.79
Position: SLIGHTLY LOW
Forward P/E & Valuation
-3.7x
Next 12M consensus est.
Wall Street Target
$6.00
+294.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.43 / $1.73
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: IKT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When IKT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: IKT is currently trading at $1.52, which is considered slightly low relative to its 30-day fair value range of $1.51 to $1.79.

Technical Outlook: Technically, IKT is in a strong downtrend. Immediate support is located at $1.43, while resistance sits at $1.73.

Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $6.00 (+294.7%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $1.51 - $1.79
Company Quality Score 48/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 82.6%

Trading Range & Key Levels

30-Day Trading Range $1.51 - $1.79
Current vs Trading Range SLIGHTLY LOW
Support Level $1.43
Resistance Level $1.73
Current Trend Strong Downtrend
Technical data as of Nov 13, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (57/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 294.7% below Wall St target ($6.00)
  • WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -3.73
Wall Street Target $6.00 (+294.7%)
Revenue Growth (YoY) -100.0%
Share IKT Analysis

Share this live IKT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (IKT)

Bullish 3 Retail Mentions
Reddit / WSB Comments
2
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Aug 5, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish StockTwits message was posted with no accompanying news articles, indicating a positive sentiment among traders regarding $IKT.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 15, 2026 9:17 PM ET
Data refreshes hourly during market hours. Next update: 10:17 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for IKT.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals â€Ļ
STRONG BUY
30 analysts
$300 60 HOLD
VRTX
Vertex Pharmaceuticals Iâ€Ļ
STRONG BUY
32 analysts
$595 40 SELL
ONC
BeOne Medicines AG
STRONG BUY
27 analysts
$469 36 SELL
ASND
Ascendis Pharma AS
STRONG BUY
21 analysts
$315 39 SELL
PVLA
Palvella Therapeutics, Iâ€Ļ
STRONG BUY
16 analysts
$234 48 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive IKT Research Pages
IKT Technical Chart IKT Price Prediction IKT Intrinsic Value DCF IKT Earnings Date IKT Investment Advisor IKT Fair Price Analyzer IKT Target Price Playground IKT LEAP Simulator IKT Supply Chain Tear-Down IKT Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals